The DES Center

Filter Your Results

 

News

 

Abbott Vascular's Xience Prime EES Evaluated in Long Coronary Lesions

June 11, 2018 -- Findings from the multicenter Longprime registry evaluating the performance of the Xience Prime everolimus-eluting stent (Abbott Vascular) in patients with lo…

Diab8 Randomized Trial Will Evaluate Alvimedica's Cre8 Evo DES in Patients With Diabetes

June 4, 2018 -- At the EuroPCR 2018 conference held May 22 -- 25 in Paris, France, Alvimedica Medical Technologies announced the design of the company's Diab8 diabetic dru…

Onyx 1-Month OCT Study Investigates DAPT Duration in Complex Patients After Stent Implantation

May 24, 2018 -- Medtronic announced that clinical data from the independently run Onyx 1-Month OCT study were presented at EuroPCR 2018, held May 21-25 in Paris, France. Data …

Pooled Analysis Shows FFR-Guided PCI Reduces Cardiac Death and MI Compared With Medical Therapy

May 24, 2018 -- Results from a patient-level pooled analysis of the FAME 2, DANAMI-3-PRIMULTI, and COMPARE-ACUTE trials comparing fractional flow reserve (FFR)-guided percutan…

Two-Year Data Presented From MiStent DESSOLVE III Trial

May 23, 2018 -- Micell Technologies, Inc. announced that a 24-month update on the DESSOLVE III trial of the company's MiStent sirolimus-eluting absorbable-polymer cor…

BIO-RESORT Evaluates Biotronik's Orsiro DES With Ultrathin Bioresorable Polymer

May 24, 2018 -- Biotronik announced that 2-year outcome data from the BIO-RESORT randomized controlled trial were presented by Marlies M. Kok, MD, in a late-breaking clinical …

One-Year Safety and Efficacy Data Presented for CeloNova's Cobra PzF NCS Stent

May 23, 2018 -- CeloNova BioSciences, Inc. announced 1-year clinical trial results from the eCOBRA postmarket study of the company's Cobra polyzene-F (PzF) nanocoated coro…

Abbott’s New-Generation Xience Sierra Coronary Stent Receives FDA Approval

May 23, 2018 -- Abbott announced that the US Food and Drug Administration (FDA) has approved the company’s newest-generation Xience Sierra everolimus-eluting coronary st…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.